Skip to main content
IMS Events Main banner
Back

    Poster Discussion

    P-409: Real-Life Outcomes in Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM) Treated With Carfilzomib- and/or Pomalidomide-Based Regimens in the LocoMMotion and MoMMent Studies

    Wednesday, September 25, 2024
    6:40 PM – 7:00 PM East Coast USA Time
    Location: Station 3, Exhibit Hall, Pavilion 3